AltaSeal®
has been tested in First-in-Human clinical trials investigating its safety and effectivness, at European centres. In an outpatient procedure, AltaSeal®
micro-inserts were placed in women without the
need for general anaesthetic.
In addition, the device has been shown to occlude fallopian
tubes in women with hydrosalpinges who have had previous failed IVF therapy with excellent clinical results.
The development of AltaSeal®
was reported in a peer reviewed journal, the article is titled Development and Initial Clinical Experience
with AltaSeal®: A Novel Hysterscopically Placed Permanent
Contraception System. The paper concludes that to date
AltaSeal®
can efficiently occlude fallopian tubes for both prevention of
pregnancy and possibly return the rate of successful IVF treatments in women with
hydrosalpinges to levels seen in patients without hydrosalpinges.
